ASX
Starpharma Holdings Limited
SPL:ASX•Healthcare
Sensitive ASX Announcement
AstraZeneca DEP Bcl2/xL inhibitors show compelling efficacy
Published: 31/08/18, 10:00am (AEST)•4 pages